News & Updates
Filter by Specialty:

Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024
byStephen Padilla
Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.
Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024
Monthly erenumab jabs promising for chronic migraine, medication overuse headaches
28 Sep 2024
byJairia Dela Cruz
Monthly injections of erenumab help induce and sustain remission of chronic migraine and medication overuse headaches, as shown in the phase IV INOVA study.
Monthly erenumab jabs promising for chronic migraine, medication overuse headaches
28 Sep 2024
Low temperature, cold spells raise risk of hospitalization for MI
27 Sep 2024
Short-term exposure to lower air temperature and cold spells may elevate the risk of hospitalization due to myocardial infarction (MI) at a lag of 2 to 6 days, suggests a study in Sweden.
Low temperature, cold spells raise risk of hospitalization for MI
27 Sep 2024
History of depression ups risk of hepatic encephalopathy in cirrhosis patients
27 Sep 2024
byStephen Padilla
Patients with cirrhosis who have a history of depression are at greater risk of developing hepatic encephalopathy, reveals a study.